Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IL15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101926887 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAPSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTN3A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB27B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNFX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C21orf91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on